HIV
Gilead Sciences Inc. has been developing lenacapavir, a first-in-class HIV capsid inhibitor, for human immunodeficiency virus (HIV) prevention as pre-exposure prophylaxis (PrEP). The research concluded that lenacapavir holds potential for helping to end new HIV infections around the world. The company is committed to working with scientists, clinicians, communities, advocates,
HIV
Research findings from a study published in "Communication & Medicine" have shed light on the implications of HIV status disclosure among pregnant and postpartum women in Southwestern Uganda. The study, conducted by researchers from the University of California San Francisco (UCSF), highlights the complexities of HIV disclosure and
HIV
A recent study published in F1000Research demonstrated the effectiveness of a mobile health educational program in increasing mental health and HIV prevention among deaf individuals. The program, designed to address the unique challenges faced by deaf persons during the COVID-19 pandemic, involved a quasi-experimental design with a non-randomized controlled trial.
HIV
Researchers at the University of Porto have developed a novel mathematical model to capture the coinfection dynamics of HIV and SARS-CoV-2 under the influence of highly active antiretroviral therapy (HAART). The model takes into account the effect of HAART on both infections and derives the basic reproduction numbers for each
HIV
Recent research from Simon Fraser University has shed new light on the persistence of hypermutated proviruses in people living with HIV, despite antiretroviral therapy (ART). The study, published in the journal Virus Evolution, found that hypermutated proviruses, which arise from the action of host antiviral APOBEC3 proteins, are present in
HIV
A new study highlights the challenges posed by low-level viremia in HIV/AIDS patients, even when they are receiving effective antiretroviral therapy. The study, conducted in Chongqing, China, shows that despite the use of effective antiretroviral therapy, low-level viremia remains a significant issue, with reported prevalence rates ranging from 10-46%
HIV
Recent research conducted at Imperial College London has made significant breakthroughs in the treatment of HIV/AIDS. The study assessed the effectiveness of the WHO-recommended first-line dolutegravir-based antiretroviral therapy (ART) in programmatic settings in low- and middle-income countries (LMICs). The research revealed that adults receiving this treatment achieved high viral
HIV
Researchers at Government Dental College and Research Institute in Karnataka, India, have conducted a study on the effects of HIV infection on oral epithelium in patients with and without highly active anti-retroviral therapy (HAART). The study found that retroviral infection and its treatment induce significant changes in oral epithelium, and
HIV
Fresh data on the association between HIV infection and the risk of long COVID has been presented in a new report. Research from the University of Missouri and the National Institutes of Health has found that people with HIV may be at increased risk for long COVID after acute SARS-CoV-2
HIV
A recent study has shed light on changes in body mass index (BMI), systolic and diastolic blood pressure (SBP and DBP), and lipid profile in patients initiating efavirenz/tenofovir disoproxil fumarate/emtricitabine (EFV/TDF/FTC) or dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) antiretroviral therapy (ART) regimens during acute HIV infection
HIV
Research conducted by Banu Humeyra Keskin and colleagues at the Zonguldak Gynecology and Pediatrics Hospital in Turkey has investigated the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections among healthcare workers in the hospital. The study retrospectively analyzed the records of 364
HIV
Young men who have sex with men (YMSM) in Taiwan are disproportionately at risk for HIV infection, with limited knowledge about their intention to use oral rapid self-testing (ORST) for HIV. A recent study conducted by researchers from the National Taiwan University found that YMSM in Taiwan have a higher
